Login / Signup

Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early- to Mid-Stage Parkinson's Disease Modification Trials.

Nirosen VijiaratnamChristine GirgesDilan AthaudaAlexa KingGrace AuldRachel McComishKashfia ChowdhurySimon SkeneKate MaclaganKallol Ray ChaudhuriVincenzo LibriJohn DicksonThomas Foltynie
Published in: Movement disorders clinical practice (2024)
These data suggest that DAT SBR could be a useful biomarker in disease-modifying trials, but a focus on anterior striatal subregions and incorporating disease duration into analyses may improve its utility.
Keyphrases
  • parkinson disease
  • functional connectivity
  • electronic health record
  • uric acid
  • metabolic syndrome
  • transcription factor
  • data analysis
  • deep learning
  • artificial intelligence